SJ
Simmons Jeffrey N
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the detailed record of transactions filed by Simmons Jeffrey N, 董事长兼首席执行官. Insider active across 2 companies, notably Elanco Animal Health Inc. In total, 23 filings have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €2.6m. Activity tracked since 11 August 2021. The latest transaction was disclosed on 3 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Simmons Jeffrey N
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
37,898 股@ US$24.8815.1% 占其流量Common StockSEC:0001479079-26-000013:0
397,041 股0Common StockSEC:0001479079-26-000011:0
22,000 股@ US$21.74989.0% 占其流量Common StockSEC:0001479079-25-000017:0
265,252 股0Common StockSEC:0001415889-25-007082:0
75,721 股@ US$11.1716.2% 占其流量Common StockSEC:0001415889-25-006627:0
449,408 股0Common StockSEC:0001415889-25-005164:0
100,000 股@ US$13.006123.7% 占其流量Common StockSEC:0001415889-24-021121:0
11,012 股@ US$15.993.2% 占其流量Common StockSEC:0001415889-24-007220:0
187,150 股0Common StockSEC:0001415889-24-006648:0
148,084 股0Common StockSEC:0001415889-24-005975:0
15,000 股@ US$9.59812.7% 占其流量Common StockSEC:0001415889-23-004744:0
10,696 股@ US$11.102.2% 占其流量Common StockSEC:0001415889-23-004468:0
316,386 股0Common StockSEC:0001415889-23-004353:0
12,662 股@ US$11.262.7% 占其流量Common StockSEC:0001415889-23-004289:0
30,000 股@ US$14.53828.7% 占其流量Common StockSEC:0001415889-22-009497:0
10,688 股@ US$27.955.0% 占其流量Common StockSEC:0001415889-22-002744:0
88,114 股0Common StockSEC:0001415889-22-002472:0
229,655 股0Common StockSEC:0001179110-22-001597:0
15,814 股@ US$33.668.5% 占其流量Common StockSEC:0001179110-21-009594:0
16,850 股@ US$29.708.0% 占其流量Common StockSEC:0000950138-21-000410:0
9,843 股Common StockSEC:0000059478-16-000310:0
4,553 股Common StockSEC:0000059478-16-000310:1
19,344 股Common StockSEC:0000059478-16-000270:0
About Simmons Jeffrey N
Simmons Jeffrey N is President and Chief Executive Officer. He has 23 filings in total, and across the 23 recent filings held, the transactions are attributions, with EUR 2,596,038 of buys and EUR 0 of sells, between 2016-01-28 and 2026-03-05. His listed companies are Elanco Animal Health Inc, where he is PRESIDENT, CEO AND DIRECTOR, and LILLY ELI & CO, where he is SVP&Pres. Elanco Animal Health.